Ocular Therapeutix Inc (OCUL)

R&D Expenses

$54.14M

Quarterly · Period ending: · USD

OCUL logo

OCUL R&D Expenses

Latest reported$54.14M
OCUL Quarterly R&D Expenses ($2.49M → $54.14M)
High-resolution chart · PNG

OCUL r&d expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Ocular Therapeutix Inc R&D Expenses — Quarterly (USD)
Period endingR&D Expenses (USD)
54,138,000
66,213,000
50,800,000
52,358,000
51,081,000
42,857,000
40,989,000
37,054,000
28,857,000
20,735,000
16,195,000
15,019,000
15,094,000
14,747,000
13,543,000
13,719,000
13,100,000
13,100,000
12,578,000
12,719,000
13,859,000
10,927,000
7,624,000
6,951,000
8,021,000
6,098,000
10,125,000
10,235,000
9,414,000
11,317,000
10,258,000
9,685,000
8,745,000
8,227,000
7,908,000
8,126,000
8,117,000
6,729,000
7,328,000
5,686,000
6,978,000
7,073,000
6,886,000
8,263,000
6,743,000
4,719,000
5,148,000
4,482,000
4,292,000
4,958,000
2,842,000
2,784,000
2,404,000
2,487,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.